# Hangzhou Sumgen Biotech

Source: https://onco.cc/companies/hangzhou-sumgen-biotech/  
OnCo record `hangzhou-sumgen-biotech` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Hangzhou Sumgen Biotech is a China-based biotechnology company running 2 late-stage cancer trials of SG2918 and SG301 in multiple myeloma.

## Summary

Hangzhou Sumgen Biotech, based in Hangzhou, China, is a biotechnology company. Sumgen Biotech is a biotech company focused on innovative drug development in oncology, specialising in antibody drugs including monoclonal antibodies and antibody-drug conjugates. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing SG2918 and SG301 in multiple myeloma. The largest, NCT06508983 (A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients), plans to enrol 360 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Hangzhou Sumgen Biotech Co., Ltd.
- Tags: ctgov-sponsor
- HQ: Hangzhou
- Type: biotech
- Website: https://www.sumgenbio.com

## Sources

- Official website: https://www.sumgenbio.com
- ClinicalTrials.gov: trials led by Hangzhou Sumgen Biotech: https://clinicaltrials.gov/search?lead=Hangzhou%20Sumgen%20Biotech%20Co.%2C%20Ltd.

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- drugs: [SG301](https://onco.cc/drugs/sg301/)
- trials: [A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients](https://onco.cc/trials/nct06508983/), [To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma](https://onco.cc/trials/nct07454187/)

---
JSON: https://onco.cc/api/v1/entities/hangzhou-sumgen-biotech.json